Kojin Therapeutics
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $30M
Investors
- 8
About Kojin Therapeutics
Founded in 2020 and based in Massachusetts, US, Kojin Therapeutics, Inc. operates as a biotechnology company that focuses on oncology and cell state biology. The company was co-founded by Benjamin Cravatt, Stephanie Dougan, Stuart L. Schreiber, and Vasanthi Viswanathan. The company’s technology is ferroptosis-based drug discovery, which is to say, iron-dependent cell death. Kojin develops therapies for hard-to-treat diseases, which include drug-resistant cancers, involve diseased cells that are sensitive to ferroptosis. Kojin’s technology platform leverages a novel non-genetic classification of cell states that allows them to understand how a cell responds to its environment and to a specific compound or molecule. It finds specific drug targets by connecting complex cell states to known biochemical processes, such as ferroptosis.
Who invested in Kojin Therapeutics
8 investors across 1 round
See all investors in Kojin Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 2, 2021
Amount
$30M
Investors
Questions about Kojin Therapeutics
Who invested in Kojin Therapeutics?
Kojin Therapeutics has 8 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Kojin Therapeutics raised?
Kojin Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Kojin Therapeutics last raise money?
Kojin Therapeutics's most recent round on record is a Series A, in Jun 2021.
What does Kojin Therapeutics do?
Founded in 2020 and based in Massachusetts, US, Kojin Therapeutics, Inc.
Where is Kojin Therapeutics headquartered?
Kojin Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Kojin Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Kojin Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Kojin Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.